Delivery Order SPE2DB22D3004-SPE2DB24FQA54
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,954.08 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, with a performance period through May 1, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,564,839,949 units of Cyclosporine 0.05% eye emulsion. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $30,801.63 and a completion date of June 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.38 Firm Fixed Price Delivery Order is for the supply of Cyclosporine 0.05% Eye Emulsion in 60-count packaging, with a completion date of March 1, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,137.33 firm fixed-price delivery order is for the supply of 60 units of 0.05% cyclosporine eye emulsions. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,829.26, is for the delivery of Cyclosporine 0.05% Eye Emulsion in 60-count packages. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 7, 2024. The contract is not set aside for any specific business category. Amerisourcebergen, through its extensive supply...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,173.44 Firm Fixed Price Delivery Order covers the provision of 4566640860 - Cyclosporine 0.05% Eye Emulsion 60s, with a completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a $1,999.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is to provide 4564599087 - CYCLOSPORINE 0.05% EYE EMULS 30S, with a performance period ending on May 15, 2024. The award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Cyclosporine 0.05% eye emulsion medication. The contract has a potential value of $1,954.08 and a performance period through February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,555.18, is a delivery order for the supply of CYCLOSPORINE 0.05% EYE EMULS 30S, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2023 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The $10,634.42 firm fixed price delivery order is for the supply of Cyclosporine 0.05% eye emulsion, a critical pharmaceutical product. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQA54Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $3,144.38 firm fixed-price delivery order contract to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is for the supply of 4564313232 - Cyclosporine 0.05% eye emulsion with an ultimate completion date of April 18, 2024. Amerisourcebergen holds a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 4/17/24 |